Nomax Inc: Drug Recall

Recall #D-0464-2024 · 04/19/2024

Class II: Risk

Recall Details

Recall Number: D-0464-2024
Classification: Class II
Product Type: Drug
Recalling Firm: Nomax Inc
Status: Ongoing
Date Initiated: 04/19/2024
Location: Saint Louis, MO, United States
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 4648 cartons

Reason for Recall

Failed Impurities/Degradation Specifications: The Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to the current USP monograph in regard to Unspecified Impurities.

Product Description

FUL-GLO, Fluorescein Sodium Sterile Ophthalmic Strips USP (0.6 mg Fluorescein), 300 sterile strips per carton, Manufactured for: Akorn, Inc., Lake Forest, IL 60045, NDC 17478-403-03.

Distribution Pattern

Nationwide in the USA

Other Recalls by Nomax Inc

Class II: Risk 04/19/2024

Failed Impurities/Degradation Specifications: The Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to the current USP monograph in regard to Unspecified Impurities.
Class II: Risk 04/19/2024

Failed Impurities/Degradation Specifications: The Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to the current USP monograph in regard to Unspecified Impurities.
Class II: Risk 04/19/2024

Failed Impurities/Degradation Specifications: The Active Pharmaceutical Ingredient (API) used in the product is not being manufactured to the current USP monograph in regard to Unspecified Impurities.
Class III: Low Risk 04/13/2021

Subpotent Drug

View all recalls by Nomax Inc →

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.